登录 | 注册    关注公众号  
微信公众号
搜索
 >  Protein>IDO1 >ID1-H5143

Human IDO1 Protein, His Tag (active enzyme)

此产品为在研产品。如果您对此产品有兴趣,请直接联系我们。我们会根据您的需求相应地加速我们的研发进程,并为您进行产品预留。

分子别名(Synonym)

IDO, IDO-1, INDO

表达区间及表达系统(Source)

Human IDO1 Protein, His Tag (ID1-H5143) is expressed from E. coli cells. It contains AA Ala 2 - Gly 403 (Accession # P14902-1).

Predicted N-terminus: Met

蛋白结构(Molecular Characterization)

IDO1 Structure

This protein carries a polyhistidine tag at the N-terminus.

The protein has a calculated MW of 47.1 kDa. The protein migrates as 43-48 kDa under reducing (R) condition (SDS-PAGE).

内毒素(Endotoxin)

Less than 1.0 EU per μg by the LAL method.

纯度(Purity)

>95% as determined by SDS-PAGE.

制剂(Formulation)

Please contact us for detailed information.

Contact us for customized product form or formulation.

运输(Shipping)

This product is supplied and shipped with dry ice, please inquire the shipping cost.

存储(Storage)

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

  1. The product MUST be stored at -70°C or lower upon receipt;
  2. -70°C for 3 months under sterile conditions.
 

背景(Background)

This gene encodes indoleamine 2,3-dioxygenase (IDO) - a heme enzyme that catalyzes the first and rate-limiting step in tryptophan catabolism to N-formyl-kynurenine. This enzyme acts on multiple tryptophan substrates including D-tryptophan, L-tryptophan, 5-hydroxy-tryptophan, tryptamine, and serotonin. This enzyme is thought to play a role in a variety of pathophysiological processes such as antimicrobial and antitumor defense, neuropathology, immunoregulation, and antioxidant activity. Through its expression in dendritic cells, monocytes, and macrophages this enzyme modulates T-cell behavior by its peri-cellular catabolization of the essential amino acid tryptophan.

 

前沿进展

 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
IDO1靶点信息
英文全称:Indoleamine 2,3-dioxygenase
中文全称:吲哚胺2,3-双加氧酶
种类:
上市药物数量:0详情
临床药物数量:14详情
最高研发阶段:临床三期
查看更多信息
前沿进展
点击查看详细
相关产品
View All IDO1

消息提示

请输入您的联系方式,再点击提交!

确定